Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression - PubMed (original) (raw)
. 1998 Apr 1;160(7):3502-12.
Affiliations
- PMID: 9531312
Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression
J Zamorano et al. J Immunol. 1998.
Abstract
Cytokines play an essential role in the regulation of lymphocyte survival and growth. We have analyzed the pathways activated by IE-2 that lead to protection from apoptosis and cell proliferation. IL-2 can act as a long-term growth factor in 32D cells expressing the wild-type human (hu)IL-2R beta. By contrast, cells expressing a truncated form of the huIL-2R beta, which is able to induce Bcl-2 and c-myc expression but not STAT5 activation, were not protected from apoptosis by IL-2; consequently, they could not be grown long term in the presence of IL-2. However, IL-2 promoted cell cycle progression in cells bearing the truncated huIL-2R beta with percentages of viable cells in the G0/G1, S, and G2/M phases similar to cells expressing the wild-type huIL-2R beta. Transplantation of a region from the erythropoietin receptor, which contains a docking site for STAT5 (Y343) to the truncated huIL-2R beta, restored the ability of IL-2 to signal both activation of STAT5 and protection from apoptosis. By contrast, transplantation of a region from the huIL-4R alpha containing STAT6 docking sites did not confer protection from apoptosis. These results indicate that the IL-2-induced cell cycle progression can be clearly distinguished from protection from apoptosis and that STAT5 participates in the regulation of apoptosis.
Similar articles
- Signal transduction mediated by the reconstituted IL-2 receptor. Evidence for a cell type-specific function of IL-2 receptor beta-chain.
Minami Y, Oishi I, Liu ZJ, Nakagawa S, Miyazaki T, Taniguchi T. Minami Y, et al. J Immunol. 1994 Jun 15;152(12):5680-90. J Immunol. 1994. PMID: 8207200 - [Roles of protein tyrosine kinases in activation, proliferation and apoptosis of immuno-hematopoietic cells].
Minami Y, Sada K, Oishi I, Yamamura H. Minami Y, et al. Tanpakushitsu Kakusan Koso. 1996 Sep;41(12 Suppl):1666-72. Tanpakushitsu Kakusan Koso. 1996. PMID: 8890621 Review. Japanese. No abstract available. - The IL-2/IL-2 receptor system: a current overview.
Taniguchi T, Minami Y. Taniguchi T, et al. Cell. 1993 Apr 9;73(1):5-8. doi: 10.1016/0092-8674(93)90152-g. Cell. 1993. PMID: 8462103 Review. No abstract available.
Cited by
- The role of protein modifications of T-bet in cytokine production and differentiation of T helper cells.
Oh S, Hwang ES. Oh S, et al. J Immunol Res. 2014;2014:589672. doi: 10.1155/2014/589672. Epub 2014 May 13. J Immunol Res. 2014. PMID: 24901011 Free PMC article. Review. - Transcriptome profiles associated with selenium-deficiency-dependent oxidative stress identify potential diagnostic and therapeutic targets in liver cancer cells.
Gözen D, Kahraman DC, Narci K, Shehwana H, Konu Ö, Çetin-Atalay R. Gözen D, et al. Turk J Biol. 2021 Apr 20;45(2):149-161. doi: 10.3906/biy-2009-56. eCollection 2021. Turk J Biol. 2021. PMID: 33907497 Free PMC article. - Immunomodulatory cytokines as therapeutic agents for melanoma.
Nicholas C, Lesinski GB. Nicholas C, et al. Immunotherapy. 2011 May;3(5):673-90. doi: 10.2217/imt.11.45. Immunotherapy. 2011. PMID: 21554095 Free PMC article. Review. - NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3.
Kim BH, Jee JG, Yin CH, Sandoval C, Jayabose S, Kitamura D, Bach EA, Baeg GH. Kim BH, et al. Mol Cancer. 2010 Feb 11;9:36. doi: 10.1186/1476-4598-9-36. Mol Cancer. 2010. PMID: 20149240 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous